Koolhaas, 1999). Furthermore, administration of V1aR receptor (V1aR) exhibit a profound impairment in soantisense oligos into the septal region resulted in imcial recognition and changes in anxiety-like behavior.
Post hoc analysis revealed that wt mice bilaterally infor the V1aR antagonists and then assessed the effects jected with vehicle into the lateral septum showed a of these bilateral injections on social recognition in orsignificant decrease in social olfactory investigation der to determine the importance of both the specific upon subsequent presentations of the same female in receptor subtype and the neuroanatomical specificity trials 2 (p < 0.001), 3 (p < 0.001), and 4 (p < 0.001) as of receptor activation on normal social recognition becompared to trial 1. The mice treated with the antagohavior.
nist had significantly impaired social recognition and We then used the results from these antagonist never demonstrated a significant reduction in olfactory studies to determine which regions should be targeted investigation in any of the trials (Figure 1 ). The olfactory with the V1aR viral vector in both V1aRKO and wt mice. investigation decrease seen in the vehicle-treated wt The V1aRKO mice treated with the V1aR viral vector subjects in trials 2, 3, and 4 was not due to a general had renewed V1aR binding in only those areas tardecrease in olfactory investigation, because presentageted, while the wt mice had increased V1aR bindings tion of a novel female during trial 5 resulted in a similar in the specific areas targeted. Social recognition and amount of investigation as trial 1 with the original anxiety-related behavior was then assessed in these female. groups in order to determine the neuroanatomical V1a Receptor Antagonist in Medial Amygdala specificity and behavioral dependence on V1aR bindWt mice bilaterally injected into the medial amygdala ing in discrete brain regions. These studies demonwith either V1aR antagonist or vehicle showed no defistrate that viral vector gene transfer used in conjunccits in social recognition. The results of this study definitively establish a role for the amount of initial investigation in either test. the lateral septum in V1aR-regulated social recognition Receptor Autoradiography in male mice. Furthermore, these findings suggest that, There was no effect on V1aR binding of the LacZ virus while both the lateral septum and medial amygdala treatment in the V1aRKO. The LacZ-treated V1aRKO have been previously shown to be important regions had a complete lack of V1aR binding throughout the for social recognition, it is V1aR in the lateral septum brain including the lateral septum ( Figure 7C ). The NSEand not in the medial amygdala that is critical to social V1aR viral vector treatment into the lateral septum rerecognition, and the social behavior effects of a null sulted in very high levels of V1aR binding in the lateral mutation in the V1aR gene can be reversed by V1aR septum; however, there was some spread into the suractivation in the lateral septum alone. In addition, these rounding regions including the medial septum ( thus may be responsible for the underlying social recognition that is the foundation for the complex social behaviors.
Social Recognition
Social recognition tasks were originally introduced as The ability to recognize a familiar conspecific is the foundation for all social relationships, including parentnonaversive alternatives to the traditional avoidance tests . These findings suggest that the medial amygdala is involved in the regulation of soKoolhaas, 1997, 1999). V1aR antisense oligos have also been shown to disrupt normal social recognition and cial recognition but it was unclear whether AVP transmission is required in this area. The current findings alter anxiety-related behavior in male rats when injected into the lateral septum (Landgraf et al., 1995) . In suggest that V1aR activation is not required in the medial amygdala and that V1aR expression is required contrast, social recognition in female rats is independent of vasopressin transmission, which is probably only in the lateral septum for normal social recognition to occur. The role of the BNST in vasopressin effects due, in part, to the sexual dimorphism of the extrahypothalamic AVP system, which is markedly reduced in feon social recognition is still unclear and was not investigated in the current studies. males (Bluthe and Dantzer, 1990; de Vries and Miller, 1998) . While the importance of the lateral septum in va-A mechanism to increase the duration of social memory would be critical to establishing dominant-subordisopressinergic social recognition has been well established in rats, the lack of septal research in mice necesnate relationships and pair bonding in monogamous species, which are examples of long-term social memsitated the current studies. Furthermore, the lateral The initial behavioral phenotyping of the V1aRKO mice the viral vector used in this study has a neuron-specific found no effect of the null mutation on hippocampalpromoter but not a V1aR neuron-specific promoter; dependent learning as assessed by the Morris water thus, it is probable that the V1aR is being expressed in maze (MWM) and found that the non-hippocampalgenes that would not normally express this gene; howdependent impairment in social recognition was conever, it is probably not expressed in glia. Even in light current with a decrease in anxiety (Bielsky et al., 2004). of these shortcomings, the current NSE-V1aR viral vecThese findings cannot be accounted for by a correlator has been used with great efficacy and provides an tion between decreased anxiety-like behavior and imimportant model for the study of the behavioral effects provement in hippocampal-dependent learning, as the of regional changes in gene expression. relationship in the V1aRKO mice was found to be the opposite. Furthermore, the current findings demonstrate Anxiety-Like Behaviors a facilitation of social recognition in both the V1aRKO Pharmacological evidence for the role of AVP and the and wt animals that received V1aR viral vector injection V1aR in anxiety-related behavior in rats has historically but opposing effects on anxiety-like behavior. The V1aRKO been contradictory. One group has reported an anxiomice that received V1aR reexpression showed a trend lytic effect of AVP administration and no effect of AVP toward decreased anxiety (although this was not signifantagonists, while others have reported no effect of icant), while the wt mice that received V1aR overexpres-AVP administration but an anxiolytic effect of V1aR ansion showed an increase in anxiety. These opposing eftagonist (Liebsch et al., 1996; Appenrodt et al., 1998).
fects on anxiety-related measures taken in concert with Still another group reported an anxiogenic-like effect the effects on social memory and the previous MWM after treatment with an AVP receptor antagonist (Everts findings therefore suggest that the relationship beand Koolhaas, 1999). Treatment with an orally active tween hippocampal-dependent learning and anxiety is V1bR antagonist resulted in a decrease in anxiety-like not relevant here. behavior in rats; however, a study of V1bRKO mice reThe current findings suggest that the lateral septum ported no effect of the null mutation in anxiety-related may provide a convergence or relay point in the social behavior ( dial to the central amygdala and basolateral amygdala nuclei. The medial amygdala complex includes the basomedial amygdala nuWt Mice cleus, the posterodorsal medial amygdala nucleus, and the posSubjects were male C57/BL6 mice ordered from Jackson Laborateroventral medial amygdala nucleus. Any injections outside these tory (Bar Harbor, ME). Four groups of wt male mice were used in parameters were excluded. the antagonist studies: experimental groups receiving a V1aR antagonist treatment into the lateral septum (n = 9) or the medial amygdala (n = 8), and control groups receiving vehicle into the latViral Vector Injections eral septum (n = 8) or medial amygdala (n = 7). Two groups of wt V1aRKO and wt animals were site specifically injected bilaterally male mice were used in the viral vector studies: an adeno-associinto the lateral septum with either adeno-associated V1aR viral ated NSE-V1aR viral vector treatment group (NSE-V1aR) (n = 11) or vector (NSE-V1aR) or control LacZ viral vector. Animals were anesa control LacZ viral vector treatment group (LacZ) (n = 10). thetized with isoflurane anesthesia administered using an anesthesia airflow machine (Vetequip, CA) and placed into Kopf stereotaxic V1aRKO Mice apparatus using blunt earbars to prevent eardrum puncture. CoorSubjects were knockout mice (−/−) (V1aRKO) bred in our laboratory.
dinates for the lateral septum were determined by dye injections (latBriefly, the mice were produced by standard homologous recombieral septum: AP +0.6 mm, ML ±0.4 mm, DV −4.0 mm from dura). The nation in which neo gene replacement deleted a 1.5 kb fragment of scalp was incised, and a dental drill was used to create a 1 mm 3 hole the V1aR gene starting at 31 bp downstream of the translation start in the skull, whereupon a Hamilton syringe was lowered, and 0.5 l/ site and ending at 244 bp downstream of exon #I. Chimeric males side of NSE-V1aR was injected. The production of the NSE-V1aR were generated and mated to C57/BL6 females, and germline transhas been previously described in detail (Pitkow et al., 2001 ). Briefly, mission was achieved. These animals were backcrossed to 129/SvJ the neuron-specific enolase (NSE) prairie vole NSE-V1aR consists for five generations, and experimental mice were produced from of a V1aR genomic clone with the majority of the intron removed, heterozygote crossings (Hu et al., 2003) . The genotype of all anispliced downstream of a rat NSE promoter. The V1aR modified semals was assessed using a PCR-based genotyping protocol as quence contains the first and second exons separated by a 287 previously described (Bielsky et al., 2004) . Two groups of V1aRKO bp intron and a 227 bp 5#-untranslated region. The NSE promoter male mice were used in these studies: an adeno-associated NSErestricts expression to neurons, and transduction by AAV-2 vectors V1aR viral vector treatment group (NSE-V1aR) (n = 15), and a coninto the brain is usually confined to neurons (Peel et al., 1997; Barttrol LacZ viral vector treatment group (LacZ) (n = 8).
lett et al., 1998; Nair and Young, 2002). The LacZ virus was prepared very similarly, by incorporating a 0.6kb cytomegalovirusAntagonist Injections immediate early promoter and the 3.7kb Escherichia coli lacZ gene On the afternoon before behavior testing, animals were site specifsequence. The packaging of AAV plasmids was performed using ically injected bilaterally into either the lateral septum or the medial the standard methods previously described. AAV vector stock was amygdala with either 5 ng of V1aR antagonist or vehicle (Ringer's titrated using real-time PCR and averaged 1 × 10 11 /ml. The viral solution). Antagonist dose was chosen based on previous findings vector was completely free of the contaminating helper virus and using site-specific antagonist injections .
only contained the gene of interest with no viral genes. The NSEAnimals were anesthetized with isoflurane anesthesia adminisV1aR was dissolved in lactated Ringer's solution so that each anitered using an anesthesia airflow machine (Vetequip, CA) and mal received a total of 0.5 l/side. Bilateral control injections were placed into Kopf stereotaxic apparatus using blunt earbars to pregiven in the same manner using 0.5 l/side of LacZ viral vector. vent eardrum puncture. Coordinates for the lateral septum and Bilateral injections were given using an automatic micropump medial amygdala were determined by dye injections (lateral sep-(World Precision Instruments, FL) at a rate of 1 nl/s. After surgery, tum: AP +0.6 mm, ML ±0.4 mm, DV −4.0 mm from dura; medial animals were removed from the anesthesia setup and generally amygdala: AP −1.8 mm, ML ±2.6 mm, DV −5.4 mm from dura). The awakened between 2 and 7 min after the surgery. Animals were scalp was incised, and a dental drill was used to create a 1 mm 
